News from invitae corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 04, 2021, 07:30 ET Invitae to Present at the Oppenheimer 31st Annual Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will present at the...

Feb 24, 2021, 07:30 ET Invitae adds Medneon's risk assessment tools to its education and clinical support offerings

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the addition of tools from Medneon, a digital health AI...

Feb 23, 2021, 07:30 ET Invitae expands capabilities of its advanced clinical chatbot Gia, enhancing telemedicine support for patients and clinicians

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced expanded capabilities that enable clinicians to use its...

Feb 22, 2021, 16:05 ET Invitae to Present at The Cowen 41st Annual Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will present at The Cowen...

Feb 17, 2021, 16:05 ET Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and full ...

Feb 10, 2021, 07:30 ET Invitae to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will present at the 10th...

Feb 03, 2021, 07:30 ET Invitae to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2020...

Jan 26, 2021, 16:05 ET Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Underwritten Public Offering

Invitae Corporation (NYSE: NVTA) today announced the closing of its underwritten public offering of 8,932,038 shares of its common stock, including...

Jan 21, 2021, 20:37 ET Invitae Announces Pricing of Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to ...

Jan 20, 2021, 16:05 ET Invitae Announces Proposed Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $400.0 million of shares of its common...

Jan 14, 2021, 07:30 ET Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the launch of a new project with Bristol Myers Squibb, Janssen...

Jan 11, 2021, 07:30 ET Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2020 results, reporting strong growth ...

Dec 29, 2020, 07:30 ET Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of...

Dec 17, 2020, 07:30 ET Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster

Invitae (NYSE: NVTA), a leading medical genetics company, today announced all patients who undergo exome testing with Invitae will receive routine...

Dec 09, 2020, 07:30 ET Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium

Invitae (NYSE: NVTA), a leading medical genetics company, today announced three studies demonstrating the benefits of genetic testing for all breast...

Nov 19, 2020, 10:57 ET New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients

Invitae (NYSE: NVTA), a leading medical genetics company, today presented study findings that show nine percent of patients with pancreatic cancer...

Nov 05, 2020, 16:05 ET Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the third quarter ended...

Oct 28, 2020, 07:30 ET Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate Cancer, Suggests Role for Broader Screening

Data presented by Invitae (NYSE: NVTA), a leading medical genetics company, at the American Society of Human Genetics (ASHG) Virtual Meeting found...

Oct 23, 2020, 07:30 ET Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2020 financial results on ...

Oct 08, 2020, 07:30 ET New Study Finds Germline Genetic Testing Detects Actionable Findings Missed by Tumor-only Sequencing

Tumor-only genetic sequencing misses medically actionable genetic variants in cancer patients that germline genetic tests identify, according to a...

Oct 05, 2020, 07:30 ET Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that on October 2, 2020, it completed the transaction to bring...

Sep 11, 2020, 07:30 ET Invitae Appoints Kimber Lockhart to its Board of Directors

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Kimber Lockhart to its Board of Directors,...

Sep 03, 2020, 07:30 ET Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a nationwide study to better understand the role...

Sep 01, 2020, 07:30 ET Invitae to Participate in the Morgan Stanley Virtual Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will virtually participate...

Aug 04, 2020, 18:37 ET Invitae Reports Inducement Grants Under NYSE Rule 303A.08

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it granted restricted stock units ("RSUs") to Kenneth D....